Table 1.
Cancer | HMGA2 Status | Sample Size | Fold Change | p-Value | Reference |
---|---|---|---|---|---|
Bladder cancer | Down | 60 | −1.576 | 5.55 × 10−8 | [37] |
Brain and CNS cancer | Up | 85 | 21.74 | 8.16 × 10−5 | [38] |
Breast cancer | Up | 593 | 1.58 | 1.14 × 10−4 | TCGA |
Up | 66 | 1.57 | 0.003 | [39] | |
Down | 59 | −23.054 | 1.58 × 10−23 | [40] | |
Colorectal cancer | Down | 40 | −2.51 | 1.15 × 10−6 | [41] |
Esophageal cancer | Up | 34 | 5.093 | 5.32 × 10−6 | [42] |
UP | 106 | 1.785 | 1.06 × 10−10 | [43] | |
Gastric cancer | Down | 132 | −1573 | 0.001 | [44] |
Head and neck cancer | UP | 99 | 2.045 | 2.05 × 10−6 | [45] |
UP | 18 | 6.098 | 3.11 × 10−5 | [46] | |
UP | 38 | 3.657 | 7.34 × 10−7 | [47] | |
UP | 18 | 9.926 | 6.31 × 10−6 | [48] | |
UP | 20 | 2.877 | 0.001 | [49] | |
UP | 54 | 2.368 | 2.06 × 10−7 | [50] | |
UP | 84 | 3.781 | 2.45 × 10−5 | [51] | |
UP | 41 | 2.130 | 5.93 × 10−5 | [52] | |
Leukemia | Down | 293 | −2.087 | 0.005 | [53] |
Lung cancer | Up | 66 | 2.320 | 3.18 × 10−5 | [54] |
Up | 246 | 3.001 | 1.39 × 10−12 | [55] | |
Up | 73 | 3.999 | 0.005 | [56] | |
Up | 156 | 11.019 | 1.01 × 10−10 | [57] | |
Lymphoma | Down | 136 | −1.798 | 1.14 × 10−11 | [58] |
Melanoma | Up | 87 | 2.664 | 8.13 × 10−4 | [59] |
Ovarian cancer | Up | 594 | 2.965 | 1.16 × 10−5 | TCGA |
Pancreatic cancer | Up | 52 | 3.629 | 1.17 × 10−7 | [60] |
Prostate cancer | Up | 15 | 126.524 | 1.15 × 10−7 | [61] |
Down | 35 | −4.150 | 9.90 × 10−6 | [62] | |
Down | 102 | −1.681 | 0.007 | [63] | |
Sarcoma | Up | 158 | 2.565 | 3.55 × 10−6 | [64] |
TCGA: The Cancer Genome Atlas Program.